No Daytime Grogginess Observed With Menopause Hot Flash Drug
Postmenopausal women taking the dual neurokinin receptor antagonist at bedtime showed greater reductions in sleepiness scores than those on placebo across 12 weeks, with the morning scores improving most. The researchers say women taking it for hot flashes and sleep problems can be reassured that grogginess the next day is unlikely, a finding that lines up with an earlier phase I study. The analysis was presented at the Menopause Society annual meeting.
For you: If hot flashes and broken sleep have put this drug on your radar, this analysis suggests morning grogginess is not part of the bargain, though it was an exploratory look rather than the trials' main question.
What it shows: Reported by MedPage Today and not verified by us: we could not trace this story to a published paper, so treat it as news rather than evidence we have checked.